SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001600132-22-000015
Filing Date
2022-04-25
Accepted
2022-04-25 08:33:28
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A blph-20220425xdefa14a.htm DEFA14A 13660
2 GRAPHIC blph-20220425xdefa14a001.jpg GRAPHIC 246302
3 GRAPHIC blph-20220425xdefa14a002.jpg GRAPHIC 234178
  Complete submission text file 0001600132-22-000015.txt   676712
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36845 | Film No.: 22847432
SIC: 2834 Pharmaceutical Preparations